Valentina Giannini, PhD, received the MS degree in Biomedical Engineering in 2007 and the PhD degree in Biomedical Engineering in 2011 at the Polytechnic of Turin, within the program "Scuola Intepolitecnica", a special project whereby the Polytechnic of Torino, in collaboration with other two Polytechnic Schools, offers a joint PhD of high qualification. She is currently a research fellow at the University of Turin. She is involved in different projects at the Candiolo Cancer Institute, FPO-IRCCS. Her current research area includes radiomics and medical image processing, more specifically the development of Computer Aided Diagnosis systems to detect, determine aggressiveness, and monitor treatments of prostate and breast cancers, using Magnetic Resonance Imaging. 

I work as a Consultant Oncoplastic Breast Surgeon in the UK. As an experienced breast clinician, I enjoy teaching and imparting my knowledge and expertise to others both in the formal and informal settings.Since graduating and obtaining my initial surgical training from Pakistan, I have maintained my links with the teaching hospitals in Karachi. This has created opportunities for me to deliver talks on breast conditions and undertake clinical and operating sessions in the teaching hospitals.Most notably, I am a tutor and an examiner of Intercollegiate MRCS  for the Royal College of Surgeons, England, both nationally and Internationally.On a local level, I have extended my expertise in guiding the sixth form students in the preparation for medical university interviews. My enthusiasm in this area led me to publish an article about this subject.Furthermore, in 2015/16, I collaborated with the consultant surgical oncologist at Maadi Military Hospital to help them in the setting up and running of Breast Services in a Military hospital in Cairo, Egypt, based on the UK model with advice to protocol and guidelines. I continued to be engaged in advising on the follow-up pathways for breast cancer patients.

Kalliopi Stefanou, is PhD-Candidate at NKUA, Medical School and master’s degree holder in HealthCare Management. Also, working as registered nurse since 2006, one year at Attikon Hospital and eleven years at Konstantopouleio Hospital. Has given several presentations in congresses (awarded at “7th Panhellenic Congress of Transfusion Therapy”-2012) and lectures to nursing specialty classes at Sismanogleio Hospital.

Prof. Dr. Zigang Li obtained his Ph.D. degree from University of Chicago and conducted his postdoc research at Harvard University. He started his independent career in Peking University since 2010, focusing on utilizing stabilized peptides to modulate important protein-protein interactions. His laboratory has published more than 60 scientific papers since 2010 and he has PIed or co-PIed more than 20 different grants.

Shu-Chun Chang is Assistant Professor of Ph.D. Program for Translational Medicine, Taipei Medical University (TMU). Dr. Chang trained in extracellular biology and glycobiology and began work on cancer research as her PhD study in 2007. Her PhD work aims to investigate the role of Hedgehog Acyltransferase (Hhat) & Heparan Sulphate Proteoglycans (HSPGs) in Human (h) Sonic Hedgehog (Shh) Signaling. These studies have great contributions in defining the functional roles of hShh interactions with HSPGs and palmitoylation of hShh in the formation of hShh multimeric complex, which allow targeting this aspect of hShh biology in tumor cell therapeutics. She continued to work in the field of Immunology/inflammation as a Post-Doc at National University of Singapore (NUS, 2011-2015). Her findings clearly identified Sensitive to Apoptosis Gene (SAG)-dependent Ubiquitin Proteasome System (UPS) as a key switch BETWEEN life and death (by apoptosis) and immune response OR immune-overactivation and pro-tumorigenesis. After four years of Post-Doc in NUS, she joined Translational Medicine group in TMU as Assistant Professor (2015-present). Her current interests are in chronic inflammation-associated cancers (e.g., lung cancer and breast cancer). Her work aims to identify key/novel molecules involved in the crossroad of immune-activation and pro-tumorigenesis, and this has a profound impact in identifying new molecular therapies for autoimmune diseases, immunodeficiency and cancers.

Dr. Tannaz Eghbali has finished her M.D. at Shiraz University of Medical Sciences. She has had research cooperation with different research centers. She is interested in research which focuses on radiology and imaging and is an active researcher at the Shiraz Breast Diseases Research Center since 2017.

Ayaka Azami, MD, is a breast surgeon Southern TOHOKU Research Institute for Neuroscience, Southern TOHOKU General Hospital, Japan. After gaining her medical degree in 2010, she received her specialist training in breast surgery at the Southern TOHOKU General Hospital, Fukushima Medical University School of Medicine, Hoshi General Hospital.

Ayda Mustafa: graduated at Faculty of Medicine University of Khartoum. Now she is now consultant general, laparoscopic and breast surgeon. Get her specialty in Breast Surgery at Athens University (2005). Associate professor at Alneelain University. She had the honor to establish Khartoum Teaching Hospital Breast Clinic (2005), followed by Khartoum Combined Breast Clinic (2010).Appointed by the Sudanese Ministry of Health to co-ordinate the National Program against Breast Cancer (2008). She Participated in Awareness programs among the Doctors in a series of Lectures as well as campaigns among medical assistance and nursing staff as well as to the public. She used to represent her country at W.H.O meetings and she is an active member at ESO, AORTIC and American Society of breast Surgeons. Now she PhD Student at Athens University the topic is: (A Comparative Study of breast cancer between Greece and Sudan). She participated in editing Guide lines for Early Detection and Management of breast cancer.

Pedro Simões Ferreira completed his master’s degree in Medicine in Nova Medical School of Universidade Nova de Lisboa in 2014 and is currently a third year resident in the Department of Physical Medicine and Rehabilitation of Centro Hospitalar Universitário Lisboa Norte – Hospital de Santa Maria. As a resident he dedicated himself to the treatment of lymphedema in patients with breast cancer and sought to better understand its risk factors and natural history in order to improve the management of this serious disease.

• PhD in clinical biochemistry, Medical and biological school, University of Southampton, England.
• Postdoctorate Fellow in medical research unit, University of Sussex, Brighton, England.
• Research Fellow, Institute of cancer research, Fox chase, Pennsylvania, USA.
• Research Associate, Albert Einstein College of medicine, New York, USA.
• Assistant professor, Faculty of medicine, Baghdad University, Baghdad, Iraq.
• Associate professor, Faculty of medicine, Baghdad University, Baghdad, Iraq.
• Professor, Faculty of medicine, Baghdad University, Baghdad, Iraq.
• Professor, Faculty of medicine, University of Mutah, Al-Karak, Jordan.
• Professor, Faculty of medicine, Hashemite University, Zerga, Jordan
• Total publications are 34 scientific papers.